Future Rheumatology

0.2(top 100%)

impact factor

216(top 50%)

papers

490(top 50%)

citations

9(top 50%)

h-index

0.2(top 100%)

impact factor

256

all documents

507

doc citations

15(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Heart rate variability as a biomarker of fibromyalgia syndrome	Future Rheumatology	2008	67
2	Is there a final common pathway for arthritis?	Future Rheumatology	2008	19
3	Inflammatory disease and sunlight: the vitamin D–poly (ADP-ribose) polymerase connection	Future Rheumatology	2008	18
4	Is aspirin treatment an appropriate intervention for osteoporosis?	Future Rheumatology	2008	17
5	Meniscectomy and osteoarthritis: what is the cause and what is the effect?	Future Rheumatology	2006	12
6	Adherence to anti-osteoporotic treatment: does it really matter?	Future Rheumatology	2006	11
7	Pre-arthritis: a concept whose time has come	Future Rheumatology	2006	10
8	Pathogenesis of Kawasaki disease: the central role of TNF-α	Future Rheumatology	2008	10
9	Role of imaging in diagnosis of and differentiation between vasculitides	Future Rheumatology	2006	10
10	Complications of anti-TNF therapies	Future Rheumatology	2007	9
11	Role of reactive oxygen species and superoxide dismutase in cartilage aging and pathology	Future Rheumatology	2008	9
12	Antimalarials in systemic lupus erythematosus: benefits beyond disease activity	Future Rheumatology	2006	8
13	Synvisc®in knee osteoarthritis	Future Rheumatology	2008	8
14	Febuxostat, a novel drug for the treatment of hyperuricemia of gout	Future Rheumatology	2008	8
15	Arthritis gene therapy at an inflection point	Future Rheumatology	2008	8
16	Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor	Future Rheumatology	2007	7
17	Angiogenesis markers in rheumatoid arthritis	Future Rheumatology	2008	7
18	Magnetic resonance imaging in ankylosing spondylitis	Future Rheumatology	2006	6
19	Future spectroscopic diagnostics in osteoarthritis	Future Rheumatology	2006	6
20	Gene therapy with the interleukin-1 receptor antagonist for the treatment of arthritis	Future Rheumatology	2006	6
21	Therapeutic approaches in bone pathogeneses: targeting the IKK/NF-κB axis	Future Rheumatology	2006	5
22	The spectrum of granulomatous vasculitides	Future Rheumatology	2006	5
23	Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with SLE	Future Rheumatology	2007	5
24	Opportunistic infections associated with TNF-α treatment	Future Rheumatology	2007	5
25	Advances in local targeted gene therapy for arthritis: towards clinical reality	Future Rheumatology	2008	5
26	Osteoarthritis genetics: current status and future prospects	Future Rheumatology	2007	5
27	New therapies for systemic lupus erythematosus: has the future arrived?	Future Rheumatology	2006	4
28	Nailfold videocapillaroscopy for the early diagnosis of systemic sclerosis in Raynaud's phenomenon	Future Rheumatology	2006	4
29	cDNA arrays in degenerative arthritis research	Future Rheumatology	2006	4
30	Computer-assisted total hip arthroplasty: the present and the future	Future Rheumatology	2006	4
31	The promise of the future, updated: better outcome tools, greater relevance, more efficient study, lower research costs	Future Rheumatology	2006	4
32	Antinuclear antibodies in systemic sclerosis	Future Rheumatology	2006	4
33	Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions?	Future Rheumatology	2006	4
34	Arachidonic acid-derived eicosanoids in rheumatoid arthritis: implications and future targets	Future Rheumatology	2006	4
35	Patellofemoral osteoarthritis: new insights into a neglected disease	Future Rheumatology	2007	4
36	Fatigue in rheumatoid arthritis: from apathy to action	Future Rheumatology	2007	4
37	Six-step management of hypertension in patients with rheumatoid arthritis	Future Rheumatology	2008	4
38	Future management of septic arthritis	Future Rheumatology	2008	4
39	Getting it right for young people: developing adolescent rheumatology services	Future Rheumatology	2008	4
40	Peptide vaccines against arthritis	Future Rheumatology	2006	4
41	Abatacept: the first-in-class costimulation blocker for the treatment of rheumatoid arthritis	Future Rheumatology	2006	3
42	Developing a gene therapy for Sjögren’s syndrome	Future Rheumatology	2006	3
43	Potential role of statins and PPARs in rheumatoid arthritis	Future Rheumatology	2006	3
44	Psoriasis occurring during anti-TNF-α therapy: causal effect or unrelated?	Future Rheumatology	2006	3
45	Genetics and clinical characteristics to predict rheumatoid arthritis: where are we now and what are the future prospects?	Future Rheumatology	2006	3
46	Roles of galectins in chronic inflammatory microenvironments	Future Rheumatology	2006	3
47	Glucosamine and osteoarthritis	Future Rheumatology	2006	3
48	T-cell-directed therapy in systemic lupus erythematosus	Future Rheumatology	2006	3
49	Use of crystalline glucosamine sulfate in osteoarthritis	Future Rheumatology	2006	3
50	Anticyclic citrullinated peptide antibodies: the footprint of autoreactive plasma cells in synovium?	Future Rheumatology	2007	3

Scientometrics

Overviews

Citing Bodies

Future Rheumatology

Top Articles